News out.... November 21, 2018 /TheNewswire/ Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MQPXF – OTC) (“Matica” or the “Company”) is pleased to announce that RoyalMax Biotechnology Canada Inc. (“RoyalMax”) has received its updated licence in accordance with Health Canada’s Cannabis Act and Cannabis Regulations and has completed its migration to the new Cannabis Act and the Cannabis Tracking and Licensing System (“CTLS”).
The Standard Cultivation License, in addition to cultivation, permits a holder to sell cannabis in accordance with subsection 11(5) of the Cannabis Regulations. This new license authorizes RoyalMax to sell dried cannabis flower, seeds and plants to other qualified license holders:
a holder of a licence for micro-cultivation or standard cultivation,
a holder of a licence for processing,
a holder of a licence for analytical testing,
a holder of a licence for research,
a holder of a cannabis drug licence; and,
it further allows sale and distribution of cannabis plants and seeds to a holder of a nursery licence or, to a holder of a license for sale, or a person authorized to sell cannabis under a provincial act.
Matica CEO, Boris Ziger states “This updated license from Health Canada will allow RoyalMax to generate potential revenues almost immediately and will enable the company to further seek out strategic partnerships such as our product research and development arrangement with Yunify Natural Technologies.”
Dorval Facility Update
Since the granting of the cultivation licence, RoyalMax and Matica have been filling positions at the Dorval indoor growing facility. Final preparations have been made for the arrival of clones. Starting materials have been ordered and are expected to arrive in the upcoming weeks. RoyalMax is required to grow two successful crops before receipt of the full sales licence.
For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
Boris Ziger
Boris Ziger, CEO & Chairman
The Company’s public filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact Boris Ziger, Chief Executive Officer, at:
Telephone: 416-304-9935